General Information of This Drug (ID: DMR24MI)

Drug Name
GSK-2256098   DMR24MI
Synonyms Focal adhesion kinase inhibitor (oral, cancer), GlaxoSmithKline
Indication
Disease Entry ICD 11 Status REF
Pulmonary arterial hypertension BB01.0 Phase 1 [1]
Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
GSK-2256098 + Carfilzomib DCJC9DM Carfilzomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
GSK-2256098 + RTB101 DC1WW0D RTB101 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
GSK-2256098 + ONC201 DCIXC8N ONC201 Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7939).
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.